Press release
Monoclonal Antibody Therapeutics Industry Growth Forecast To 2031 | Leading Companies - F. Hoffmann-La Roche, Novartis AG, Merck & Co. Inc., Pfizer Inc
Monoclonal Antibody Therapeutics Industry
Monoclonal Antibody Therapeutics Market Industry Outlook - Strategic Insights for 2025
Monoclonal Antibody Therapeutics Market is witnessing transformative growth in 2025, driven by evolving consumer demand, technology disruption, and sustainability trends. The newly released market research report by DataM Intelligence offers deep insights into segmentation, competitive landscape, and growth forecasts, helping marketers and decision-makers formulate high-impact strategies.
Get exclusive insights with our detailed sample report (Corporate Email ID to get priority access) @ https://datamintelligence.com/download-sample/monoclonal-antibody-therapeutics-market?kb
Monoclonal antibody therapeutics are lab-made molecules that mimic natural antibodies to treat diseases like cancer, autoimmune disorders, and infectious diseases by targeting specific antigens.
Leading Market players in the Monoclonal Antibody Therapeutics Market
The prominent players in Monoclonal Antibody Therapeutics market research report are:
F. Hoffmann-La Roche, Novartis AG, Merck & Co. Inc., Pfizer Inc., Eli Lilly and Co. (Lilly), Sanofi, AstraZeneca, Bayer AG, Regeneron Pharmaceuticals Inc., and GSK Plc among others.
These companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.
Industry Development
In May 2023, the U.S. Food and Drug Administration (FDA) approved the Investigational New Drug (IND) application for ATG-031, a first-in-class anti-CD24 monoclonal antibody, enabling the initiation of its Phase I clinical trial. The drug is developed by Antengene Corporation Limited, a global, commercial-stage biopharmaceutical company committed to discovering, developing, and commercializing first-in-class therapies in oncology and hematology.
In April 2023, Prometheus Biosciences, Inc., a clinical-stage biotechnology company known for its precision medicine approach to treating immune-mediated diseases, announced a definitive agreement with Merck & Co., Inc. (known as MSD outside the U.S. and Canada). As per the agreement, Merck will acquire Prometheus for $3.3 billion, strengthening its portfolio in immunology and personalized therapies.
In February 2023, Pfizer announced that its investigational bispecific antibody, Elranatamab, which targets B-cell maturation antigen (BCMA) and CD3, received Priority Review status from the U.S. FDA. The Biologics License Application (BLA) submission supports its use in patients with relapsed or refractory multiple myeloma (RRMM).
Market Segments
By Product Type: Naked, Fusion Protein, Antibody fragment, Conjugate, Multi-specific
By Application: Cancer, Autoimmune Diseases, Infectious Diseases, Others
By Production Source: Human, Humanized, Chimeric, Others
By End User: Hospitals, Private Clinics, Research Institutes
Buy Now & Unlock 360° Market Intelligence: https://datamintelligence.com/buy-now-page?report=monoclonal-antibody-therapeutics-market?kb
Research Methodology:
The global Monoclonal Antibody Therapeutics Market research report employs a comprehensive dual-source approach, integrating both primary and secondary data collection methods to ensure robust market analysis. Our research framework systematically evaluates multiple industry-influencing variables, including regulatory frameworks and government policies, prevailing market conditions, competitive intensity levels, historical performance data, current market positioning, technological innovations and disruptions, emerging industry developments, cross-sector business impacts, market volatility patterns, growth prospects, potential market barriers, and strategic challenges facing industry participants.
Speak to Our Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/monoclonal-antibody-therapeutics-market?kb
Regions Covered:
The global Monoclonal Antibody Therapeutics Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
Most Frequently Asked Questions in the Monoclonal Antibody Therapeutics Market Research Industry:
➠ Who leads the Monoclonal Antibody Therapeutics industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Monoclonal Antibody Therapeutics market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Monoclonal Antibody Therapeutics market growth?
➠ What are the dominant sales and distribution strategies in the Monoclonal Antibody Therapeutics industry?
Purchase Your Subscription to Power Your Strategy with Precision: https://www.datamintelligence.com/reports-subscription?kb
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Monoclonal Antibody Therapeutics Industry Growth Forecast To 2031 | Leading Companies - F. Hoffmann-La Roche, Novartis AG, Merck & Co. Inc., Pfizer Inc here
News-ID: 4085735 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Antioxidants Market Is Booming By Vita Foods 2026: Top Companies - Kaneka Medica …
DataM Intelligence has published a new research report on "Antioxidants Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Antioxidants Market Size reached US$ 5.34 billion in 2024…
Global Krill for Pet Food Market Trends & Industry Insights 2025 | Major Compani …
Global Krill for Pet Food Market reached US$ 410.2 million in 2022 and is expected to reach US$ 1,001.2 million by 2031, growing with a CAGR of 11.8% during the forecast period 2024-2031.
The Krill for Pet Food Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in detail, evaluating market leaders across multiple…
Herbal Supplements Market 2025: Global Trends, Opportunities & Vita Foods 2026 - …
DataM Intelligence has published a new research report on "Herbal Supplements Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Sample PDF Of This Report (Get…
Future of Animal Parasiticides Market: Sustainable and Effective Parasite Contro …
Global Animal Parasiticides market reached US$ 11.8 billion in 2022 and is expected to reach US$ 19.09 billion by 2031, growing with a CAGR of 6.2% during the forecast period 2024-2031.
The Animal Parasiticides Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in detail, evaluating market leaders across multiple dimensions including their innovative…
More Releases for Monoclonal
Rising Popularity Of Cost-Efficient Biosimilar Monoclonal Antibodies Fuels Monoc …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Monoclonal Antibodies (MAbs) Market Through 2025?
The market for monoclonal antibodies (MAbs) has experienced swift expansion in the recent past. The market value is projected to rise from $234.37 billion in 2024 to $261.66 billion in 2025, exhibiting a compound annual growth…
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market?
In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial…
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market?
In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial…
Arthritis Monoclonal Antibodies Market Report 2024 - Arthritis Monoclonal Antibo …
"The Business Research Company recently released a comprehensive report on the Global Arthritis Monoclonal Antibodies Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The arthritis monoclonal antibodies…
Biosimilar Monoclonal Antibodies Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "Global Biosimilar Monoclonal Antibodies Market by Product (infliximab, trastuzumab, rituximab, adalimumab, bevacizumab, cetuximab, ranibizumab, denosumab, eculizumab, and other pipeline products), Indication (oncology, inflammatory & autoimmune disorders, chronic diseases, blood disorders, and other indications), Clinical Trial/Pipeline Analysis, Future Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
The Biosimilar Monoclonal Antibodies Market Size is valued at 5.02…
Monoclonal Antibody Therapy Market - Empowering the immune system: Monoclonal an …
Newark, New Castle, USA: The "Monoclonal Antibody Therapy Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Monoclonal Antibody Therapy Market: https://www.growthplusreports.com/report/monoclonal-antibody-therapy-market/7736
This latest report researches the industry structure,…
